Keytruda Cancer Drug
-
{
- All
- News
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
- Saturday April 18, 2026
- Health | Written by Debosmita Ghosh
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
New Hope For Bowel Cancer: Immunotherapy Drug Offers Cure Without Surgery
- Tuesday June 4, 2024
- Science | Edited by Nikhil Pandey
A groundbreaking immunotherapy drug, Pembrolizumab (Keytruda), shows promising results in treating bowel cancer by targeting specific immune cell proteins.
-
www.ndtv.com
-
'New Day' In Lung Cancer As Merck Drug Shines, Works With Chemo
- Sunday October 9, 2016
- Health | Reuters
Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.
-
www.ndtv.com
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
- Saturday April 18, 2026
- Health | Written by Debosmita Ghosh
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
- Tuesday April 14, 2026
- Health | Written by Debosmita Ghosh
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
- Monday April 13, 2026
- Health | Written by Debosmita Ghosh
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
www.ndtv.com
-
New Hope For Bowel Cancer: Immunotherapy Drug Offers Cure Without Surgery
- Tuesday June 4, 2024
- Science | Edited by Nikhil Pandey
A groundbreaking immunotherapy drug, Pembrolizumab (Keytruda), shows promising results in treating bowel cancer by targeting specific immune cell proteins.
-
www.ndtv.com
-
'New Day' In Lung Cancer As Merck Drug Shines, Works With Chemo
- Sunday October 9, 2016
- Health | Reuters
Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.
-
www.ndtv.com